Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimetabolite radiosensitizers.

Donna S Shewach1, Theodore S Lawrence

  • 1Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, MI 48109-0504, USA. dshewach@umich.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|September 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overcoming Cetuximab Resistance in HNSCC by Hsp90 Inhibition to Enhance EGFR Degradation.

The Journal of biological chemistry·2026
Same author

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinoma.

The Journal of biological chemistry·2026
Same author

α/β for Hepatocellular Carcinoma Tumors Treated With Radiation Therapy.

International journal of radiation oncology, biology, physics·2026
Same author

FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Digital twins for in vivo metabolic flux estimations in patients with brain cancer.

Cell metabolism·2025
Same journal

Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Uncontrolled Prediabetes Confounding in the Association Between Alcohol Consumption and Young-Onset Pancreatic Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Brain-Only Progression After First-Line Therapy in Extensive-Stage Small Cell Lung Cancer: Treat the Sanctuary, Preserve the Backbone.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Reply to: "Beyond Average Grams: Aldehyde Dehydrogenase 2*2  and Alcohol-Induced Young-Onset Pancreatic Cancer" and "Uncontrolled Prediabetes Confounding in the Association Between Alcohol Consumption and Young-Onset Pancreatic Cancer".

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Beyond Average Grams: Aldehyde Dehydrogenase 2*2 and Alcohol-Induced Young-Onset Pancreatic Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Antimetabolites enhance radiation therapy for solid tumors by interfering with DNA replication and repair. Understanding their mechanisms, including DNA repair pathways and EGFR signaling, is key to optimizing cancer treatment.

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Chemistry

Background:

  • Antimetabolites are established radiosensitizers improving outcomes in solid malignancies.
  • Fluorouracil (FU), hydroxyurea, and gemcitabine are widely used antimetabolites.
  • These agents target DNA replication through various mechanisms.

Purpose of the Study:

  • To elucidate the distinct mechanisms of radiosensitization by different antimetabolites.
  • To identify DNA repair pathways involved in antimetabolite-mediated radiosensitization.
  • To explore the role of epidermal growth factor receptor (EGFR) signaling in gemcitabine's radiosensitizing effects.

Main Methods:

  • Review of existing literature on antimetabolite radiosensitization.
  • Analysis of mechanisms including enzyme inhibition (thymidylate synthase, ribonucleotide reductase) and DNA incorporation.

Related Experiment Videos

  • Investigation of DNA repair pathways (base excision repair, homologous recombination, mismatch repair).
  • Examination of gemcitabine's effect on EGFR phosphorylation.

    • Main Results:

    • Antimetabolites inhibit DNA replication via thymidylate synthase, ribonucleotide reductase, or DNA incorporation.
    • Radiosensitization involves increased DNA double-strand breaks or impaired repair.
    • Specific repair pathways implicated: base excision repair (TS inhibitors), homologous recombination (gemcitabine), mismatch repair (FU, gemcitabine).
    • Gemcitabine induces EGFR phosphorylation, which can be targeted by EGFR inhibitors.

    Conclusions:

    • Antimetabolites exhibit diverse mechanisms of radiosensitization.
    • Understanding specific DNA repair pathways and EGFR signaling is crucial for optimizing combination therapies.
    • Further research is needed to define optimal sequencing of antimetabolites, EGFR inhibitors, and radiotherapy for improved clinical protocols.